Lecture 4 - shock Flashcards

1
Q

review Preload = Central Venous Pressure (range, low, high, indication, _____ _____ where we expect ___ _______?, which shock state would we be concerned with fluid overload?

A

Range- 0-10mmHg

Low = Hypovolemia
High = Normo/Hypervolemia

Why?- Monitor Fluid status in patients who are prone to volume depletion or Volume overload

Major surgeries where we expect 3rd spacing:
Shock States where we may be concerned with fluid overload (Mainly Cardiogenic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Afterload = SVR = Systemic Vascular Resistance (measured with, range, low, high, indication, which shock would see elevation in SVR, which shock would see low in SVR)

A

Measured with Invasive hemodynamics like the EV1000, Vigileo, etc

Range- 700-1500 Dynes
Low = Vasodilation
High = Vasoconstriction
Why?- Monitor bodies response to disease state and subsequent therapy

Cardiogenic shock- expect to see elevations, medical mgmt. would reduce SVR
Septic shock- Low SVR, medical mgmt. would increase SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

review Contractility

A

Difficult to measure directly, use other determinants to assess contractility
- Ie. If SVR is high, and Preload is high, but CO is Low- what type of shock would we expect?
- You don’t know yet!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Arterial BP (what, more accurate than, used to monitor (3))

A

1) Invasive blood pressure monitoring
- More accurate than a sphygmomanometer, exists in realtime

2) Used to monitor:
- Response to vasopressor/dilator therapy
- Response to shock state treatment
- Labile blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Shock Syndrome (what, results in, imbalance between, leads to, no what what the underlying cause of shock, all shock will…)

A
  • Acute, widespread impaired tissue perfusion
  • Results in cellular, metabolic, and hemodynamic alterations
  • Imbalance between cellular oxygen supply and cellular oxygen demand
  • Often results in multiple organ dysfunction syndrome (MODS)
  • No matter what the underlying cause of shock, all shock will result in the same outcome if not treated early.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Etiology of Shock States (3 + 3 types)

A

1) Hypovolemic: Loss of circulating or intravascular volume

2) Cardiogenic: Impaired ability of heart to pump

3) Distributive: Mal-distribution of circulating blood volume
types: Septic, anaphylactic, or neurogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Shock Syndrome-Pathologic Process (4 stages)

A

Initial: Insult occurs (bacteria in blood)

Compensatory: Body is maintaining tissue perfusion. Heart rate may be elevated with normal BP. Start to see a decrease in urine output/production (KEY: WANT TO CATCH IN THIS PHASE)

Progressive: Heart rate elevated, BP drops, urine output significant decreased. Team starts to initiate fluid boluses, vasopressors. Lactic acid levels increase (anaerobic metabolism)

Refractory: Multiple organ failure. Unable to maintain tissue perfusion despite aggressive measures. (MODS OCCURS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology: Initial stage

A

Decreased CO → tissue perfusion is threatened

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology: Compensatory stage (_________ mechanisms to maintain.. (3), mediated by ______, 3 responses, ________ mechanisms may normalize -> elevations in (2))

A

1) Homeostatic mechanisms to maintain cardiac output, blood pressure, tissue perfusion
- Mediated by sympathetic nervous system:
a) Neural response
b) Hormonal response
c) Chemical response

2) Compensatory mechanisms may normalize hemodynamics:
- Elevation in HR, SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Global Indicators of Progressive Shock: (5)

A
  • Serum lactate levels increased
  • Arterial base deficit levels (acidosis)
  • Serum bicarbonate levels decreased
  • pH decreases
  • Central or mixed venous oxygen saturation levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology: Progressive stage (_______ mechanisms begin to _____, switch from _______ to ________ ________ -> _______ ____ production), increased (3) -> what? (2), what begins during this stage?)

A
  • Compensatory mechanisms begin to fail
  • Switch from aerobic to anaerobic metabolism → lactic acid production
  • Increased vascular permeability, tissue edema, and decline in tissue perfusion:
    a) Fluid immediately third spaces when administered
    b) Systemic inflammatory response (SIRS)
  • Irreversible damage begins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathophysiology: Refractory stage (3)

A
  • Unresponsive to therapy
  • Irreversible with the development of MODS
  • Death is final outcome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stages of shock - NCLEX+HESI (3 stages)

A

Initial + Compensatory, non-progressive stage (Stage 1)- Insult to compensatory mechanisms to maintain hemodynamics

Intermediate, progressive phase (Stage 2)-Need for support with fluid and medications to maintain tissue perfusion

Final, irreversible stage (Stage 3)-Multi-organ failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Consequences of shock (neuro) (3)

A

Mental status changes
Sympathetic Nervous system dysfunction
Thermal dysregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Consequences of shock (cardiac) (2)

A

Pump failure
Micro embolism of cardiac circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Consequences of shock (pulmonary) (2)

A

ALI/ARDS
Respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Consequences of shock (renal) (1)

A

Acute Tubular Necrosis: ↑BUN, Cr, ↓Urine output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Consequences of shock (GI) (3)

A

Hepatic failure -> increase liver enzymes, bilirubin, ↓ albumin, clotting protein

Pancreatic failure -> increase amylase, lipase, ↓ insulin production

GI tract failure -> Gastric immotility, SBO/ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Consequences of shock (hematologic) (1)

A

DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Goal of Treatment (2)

A

Improvement of tissue perfusion
- Adequate pulmonary gas exchange: Oxygen therapy, Ventilatory support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Shock Syndrome: Medical Management (main)

1) adequate ____ _____ and ____ (5)

2) optimal ____ _______
- ____ _____ avoided until pH less than ____
- treat (3)

3) _______ support
- as ______ as possible, ________ requires ________
- tailored to individual needs
- tight _______ control

A

Improvement of tissue perfusion:

1) Adequate cardiac output and hgb
- Fluid management
- Vasoconstrictors
- Vasodilators
- Positive inotropes
- Antidysrhythmics

2) Optimal metabolic environment
- Sodium bicarbonate avoided until pH less than 7.1
- Treat infection, reperfusion therapy, support organs to prevent further anaerobic metabolism

3) Nutritional support
- As early as possible, enteral requires MAP >60 (too low, blood shunt away from gut, risk of gastric immotility)
- Tailored to individual need
- Tight glucose control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

types of shock (4)

A

1) Hypovolemic

2) Cardiogenic

3) Distributive:
- Anaphylactic
- Neurogenic
- Septic

4) Obstructive:
- Cardiac Tamponade
- Tension Pneumothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hypovolemic Shock (3)

A
  • Inadequate fluid volume in the intravascular space
  • Decreased tissue perfusion
  • Most common form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hypovolemic Shock: Assessment and diagnosis

(4 classes, what are the percentage and mL of fluid loss)

A

Class I
- Fluid volume loss up to 15% total body fluid
- Up to 750 mL fluid loss

Class II
- Fluid volume loss 15% to 30% total body fluid
- Fluid loss 750 to 1500 mL

Class III
- Fluid volume loss 30% to 40% total body fluid
- Fluid loss 1500 to 2000 mL

Class IV
- Fluid volume loss greater than 40% total body fluid
- Fluid loss > 2000 mL
Refractory (organ failure d/t much organ loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hypovolemic Shock: Hemodynamic assessment

what happens to CO, CI, CVP, PAWP, SVR?

A

Cardiac output decreased

Cardiac index decreased

Central venous pressure decreased

Pulmonary artery occlusion pressure decreased

Systemic vascular resistance increased (threat to perfusion -> releases catecholamines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hypovolemic Shock: Medical management (3)

A

Correct hypovolemia
Restore tissue perfusion
Prevent complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hypovolemic Shock: Nursing management (4)

what can mass blood transfusions precipitate? (3)

what is in packed RBCs that bind with blood to stop clotting cascade?

A

Prevent hypovolemic shock

Minimize fluid losses

Enhance volume replacement I&O’s (treat I/O)

Maintain surveillance for complications
- Blood transfusion reactions
- mass blood transfusions can precipitate hypothermia, acidosis, hyper K, sodium citrate in blood binds with blood to stop clotting cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Cardiogenic Shock (what, etiology (3))

A

Failure of heart to pump blood effectively

etiology:
Primary ventricular ischemia
Structural problems
Dysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Cardiogenic Shock: Medical management (goals (3), what device, what procedure, other mechanical circulatory assist devices (2))

A

goals:
Treat underlying cause of pump failure
Enhance the effectiveness of the pump
Improve tissue perfusion

Intra-aortic balloon pump

Early revascularization

Mechanical circulatory assist devices
- Ventricular assist device (LVAD)
- Extracorporeal membrane oxygenation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cardiogenic Shock: Pharmacologic support (5)

A

Inotropic agents

Vasopressor (sometimes)

Diuretics

Vasodilators once blood pressure stabilized (Lower SVR comparative to Contractility)

Antidysrhythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Cardiogenic Shock: Nursing management (5)

A

Prevention of cardiogenic shock

Limit myocardial oxygen consumption

Enhance oxygen supply

Precise monitoring and management of hemodynamics

Surveillance for complications related to intra-aortic balloon pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

46-year-old female diagnosed the day prior with a saddle pulmonary embolism (big ole’ clot that blocks blood to multiple branches off the pulmonary artery), she was started with a weight-based heparin bolus and is now on a continuous drip.

The following day in the stepdown unit,
Vitals are: BP 114/72, HR 89, RR 18, Temp 98.7 F

While cardiology is rounding, she begins to decompensate,
Vitals are: BP 71/42, HR 130, RR 24, Temp 98.7F

Which of the following interventions should be expected?
A. Thrombolytic Therapy
B. Percutaneous Embolectomy (Clot retrieval)
C. 1L NS
D. Begin CPR

A

C. 1L NS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Anaphylactic Shock (3)

A

Distributive shock
Immediate hypersensitivity reaction
Life-threatening event

34
Q

Anaphylactic Shock: Medical management

1) goals (3)

2) therapy

3) pharm interventions (5)

A

Goals:
- Remove antigen
- Reverse effects of biochemical mediators
- Promote adequate tissue perfusion

Oxygen

Pharmacologic intervention:
- Epinephrine (dilates airways, constricts vasculature)
- Diphenhydramine (benadryl, releases biochemical affects)
- Pepcid (gi upset)
- Corticosteroids
- Fluid replacement

34
Q

Anaphylactic Shock

1) etiology (1)

2) Antigens (6)

3) what kind of antigen response

A

Etiology:
- Severe antibody-antigen reaction

  • Antigens:
    Foods, Food additives
    Diagnostic agents
    Biologic agents
    Environmental agents
    Drugs, Venoms
    ACE-I, bee sting, etc.
  • IgE-mediated or non–IgE-mediated
34
Q

Neurogenic Shock

1) what kind of shock, 2

2) etiology (2)

A

Distributive shock
Loss or suppression of sympathetic tone
Rarest form of shock

Etiology
- Disruption of sympathetic nervous system
- Usually seen in spinal cord injury, but not the same as spinal cord shock

34
Q

Anaphylactic Shock: Nursing management (6)

A
  • Prevention of anaphylactic shock
  • Note all allergies
  • Facilitate ventilation
  • Enhance volume replacement
  • Promote comfort and emotional support
  • Maintain surveillance for complications
35
Q

Neurogenic Shock: Assessment and diagnosis (4)

A

Hypotension
Bradycardia
Warm, dry skin
Hypothermia due to peripheral heat loss

36
Q

Neurogenic Shock: Hemodynamic assessment

what happens to CO, CI, CVP, SVR

A

Cardiac output decreased
Cardiac index decreased
Central venous pressure decreased
Systemic vascular resistance decreased

37
Q

Neurogenic Shock: Medical management

1) goals (3)

2) other interventions (3)

A

Goals
- Remove cause of neurogenic shock
- Prevent cardiovascular instability
- Restore tissue oxygenation and perfusion

  • Fluid resuscitation
  • Vasopressors
  • Warming measures
38
Q

Neurogenic Shock: Nursing management (5)

A

1) Prevent of neurogenic shock
- Immobilization of spinal cord injuries
- Slight elevation of the head of the bed after spinal anesthesia

2) Treat hypovolemia

3) Maintain normothermia

4) Monitor for dysrhythmias

5) Deep venous thrombosis prevention

39
Q

SIRS- Systemic Inflammatory Response Syndrome (what, will accompany any _____ ______ _______, examples of when SIRS can occur (6))

A

nonspecific, can exist as a result of any inflammatory response

  • Will accompany any progressive shock state
  • Ischemia, infection, trauma, inflammation, burns, pancreatitis
40
Q

SIRS 3 stages

1) 1

2) 2

3) 2

A

Stage 1:
- Cytokine production following insult/injury. Cellular inflammatory response initiated -> Local inflammation to support tissue repair and leukocyte recruitment

Stage 2:
- Cytokine release into blood stream to improve local response  Growth factor stimulation, macrophage and platelet production.
- During normal inflammatory response, pro-inflammatory mediators would drop off at this point

Stage 3:
- Loss of homeostasis leads to systemic inflammation. Wide spread activation of reticular endothelial system leads to loss of circulatory integrity.
- Relative hypovolemic shock and end-organ dysfunction

41
Q

SIRS Criteria requires at least 2 of the following clinical findings (4)

A

TEMP
>38C, <36C

HR
>90 bpm

RR
>20 or PaCo2 of less than 32

WBC
>12,000 or <4,000 or >10% Immature
Band Cells

42
Q

qSOFA (3)

A

Altered Mental Status
Fast Resp Rate
Low BP

43
Q

Severe Sepsis and Septic Shock (what, which type of shock and how?)

A

Microorganisms invade the body, initiating a systemic inflammatory response

Distributive shock: maldistribution of blood flow to the tissues

44
Q

Severe Sepsis and Septic Shock: Etiology (4)

A

Microorganisms:
- Gram-negative and gram-positive aerobes
- Anaerobes
- Fungi
- Viruses

Endogenous sources
- ex: perforated bowels (goes in perineal cavity)

Exogenous sources
- ex: anything we put in patient -> important to get lines out

Secondary infections are not uncommon

45
Q

Severe Sepsis and Septic Shock: Assessment and diagnosis (based on 3 conditions)

A

Diagnosis based on identification of three condition:
- Suspected infection
- Two or more clinical indications of the systemic inflammatory response syndrome (SIRS)
- Evidence of at least one organ dysfunction (impaired renal, AMS, Diff. breathing)

46
Q

Clinical Manifestations of Shock (early septic shock (warm/compensatory)) (8)

A

Increased HR
Full, Bounding Pulse
Pink, warm, flushed skin
Increased resp rate
Increased temp
Increased CO/CI
Decreased PaCO2
Increased ScvO2

47
Q

Clinical Manifestations of Shock (Late Septic Shock (Cold/Progressive)) (7)

A

Increased HR, decreased BP
Crackles
Markedly decreased U/O
Decreased SVR
Decreased PAOP
Decreased PaO2, HCO3
Decreased ScvO2

48
Q

Severe Sepsis and Septic Shock: Medical mgmt (what type of therapy and 3 indications)
______ _______ Directed therapy
- _______/________ infection
- reverse…
- promote…

1) secure _________, correct ________

2) _________ administration early via IV access
- iniitial bolus of ___________ for patients in septic shock (within ___ hours of presentation)
- what other intervention?

3) ___________ therapy within ___ hour

how do you draw blood cultures?

A

Early Goal Directed Therapy (EGDT)
- Control/Eliminate infection
- Reverse pathophysiologic response
- Promote metabolic support

2) Secure airway, correct hypoxemia

3) Fluid administration via early IV access
- Initial bolus of 30ml/kg for patients in septic shock (within 3 hours of presentation)
- Vasopressors

4) Antibiotic therapy – Empiric Abx for suspected organism (within 1 hour)
- Broad spectrum until cultures provide further guidance
- Vanco + 3rd or 4th gen cephalosporin –OR- beta-lactamase inhibitor (Piperacillin-tazobactam)

Antifungals when appropriate (voriconazole)

tip:
- blood cultures -> anaerobic/aerobic from 2 separate sites, 15 minutes apart (accessible site: sputum, urine, wounds, surgical sites, central lines, etc.)

49
Q

Severe Sepsis and Septic Shock: LABS (5) and tests (2)

A

labs:
- CBC w/ differential, chem, liver function, coags (including D-Dimer)
- Suggests severity and provides baseline in following response
- Lactate
- ABGs
- Peripheral blood cultures. * BEFORE ABX*
-> Anaerobic and aerobic from 2 separate sites 15 min apart ( And other potential readily accessible sites- sputum, urine, wounds, surgical sites, central lines, etc.

  • IMAGING- X-ray and CT
  • Eliminate sources of infection (if necessary)
50
Q

Severe Sepsis and Septic Shock: Nursing management (9)

A
  • Identify the sepsis syndrome (qSOFA, SIRS criteria)
  • Give fluids
  • Give medications (vasoactive agents, antibiotics, rhAPC and other drugs)
  • Prevent complications
  • Prevent other infections
  • Monitor patient’s response to therapy
  • Maintain MAP 65-70mmHg, CVP 8-12, ScvO2 >70%
  • Observe for complications
  • Collaborative management
51
Q

65-year-old female presenting with weakness, fatigue, palpitations and altered mental status- brought in via EMS

HR 170 bpm (In Atrial fibrillation with Rapid ventricular response on monitor- Afib w/rvr).

BP 72/40, RR 30, Pulse ox 92% on RA, temp 103.1

Which of the following would be expected intervention?
A: Cardiovert with 200J
B: 1L bolus of NS, followed by Vasopressor drip
C: Cardiovert with 360J
D: Defibrillate with 360J
E: Your shift is over in 30 min so let someone else worry about it.

52
Q

Shock Can Lead to _________

exam: what is it?

cause?

A

a: MODS

“Multiorgan dysfunction is the progressive physiological failure of several organ systems in acutely ill patients following an acute threat to systemic homeostasis such that homeostasis cannot be maintained without intervention.”

Cause is unknown, but any shock state can result in MODS

53
Q

Multiple Organ Dysfunction Syndrome: Gi dysfunction (GI tract contains approximately _____ to ______ of the ________ tissue of the entire body, mechanisms linking _______ ____ to ______ organ dysfunction -> (3))

A

Gastrointestinal tract contains approximately 70% to 90% of the immunologic tissue of the entire body

Mechanisms linking gastrointestinal tract to latent organ dysfunction:
- Hypoperfusion
- Translocation of gastrointestinal bacteria
- Colonization

54
Q

Multiple Organ Dysfunction Syndrome: hepatobiliary dysfunction (what, _____ and ______ can lead to liver failure, with _______ in liver enzymes)

A

Selective changes in carbohydrate, fat, and protein metabolism in response to SIRS

Shock liver and posttraumatic hepatic insufficiency can lead to liver failure
- Elevations in Liver enzymes

55
Q

Multiple Organ Dysfunction pulmonary dysfunction (frequently…, _____ organs affected in progression from ____ to _____, what 2 conditions is result?

A

Frequently early target organ

First organ affected in progression from SIRS to MODS

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS)

56
Q

MODS Renal dysfunction: (______ highly vulnerable to ________ injury, ____ or _____ s/d to decreased _________ and ________, use of __________ drugs intensifies ______ ________, what condition results?)

A

Kidney highly vulnerable to perfusion injury

Oliguria or anuria secondary to decreased perfusion and hypotension

Use of nephrotoxic drugs intensifies renal dysfunction

Acute renal failure

57
Q

MODS Cardiovascular dysfunction (initial response, what occurs as MOD progresses, what follows after? (2))

A

Initial cardiovascular response is myocardial depression

Cardiac failure as MODS progresses

Cardiogenic shock and biventricular failure follow

58
Q

MODS Hematologic system dysfunction (4)

A

Thrombocytopenia, coagulation abnormalities, anemia

Disseminated intravascular coagulation (DIC)

59
Q

Collaborative Management of High-Risk Patients: Prevention, detection, and treatment of infections (6)

A

Medical/surgical interventions to remove sources of infection or contamination

Appropriate antibiotics

Prevention of skin breakdown

Early nutritional support

Strict adherence to standards of practice to prevent infection

Prevention of ventilator-associated pneumonia
- oral care
- subglottic suction
- positioning
- adequate staffing

60
Q

Collaborative Management of High-Risk Patients: Maintenance of tissue oxygenation (what may be augmented in health care setting?, how to manage hypoperfusion and organ hypoxemia (6))

A

Supply is independent oxygen consumption - may be augmented in healthcare settings

Hypoperfusion and organ hypoxemia
- Fluid resuscitation
- Monitor arterial lactate
- Mechanical ventilation
- Temperature and pain control
- Rest
- Maintain normal hematocrit – Hgb >7

61
Q

Nursing Management of High-Risk Patients (what kind of support, hyper_____ with (3), ____ route preferred)

A

Nutritional/metabolic support
- Hypermetabolic with severe weight loss, cachexia, and loss of organ function
- Enteral route preferred

62
Q

Experimental Approaches in SIRS and MODS (4)

A

Continuous venovenous hemofiltration

Immunomodulatory strategies to prevent the conversion from SIRS to bacterial sepsis, septic shock, and MODS

Pharmacologic approaches that inhibit neutrophil function

Other therapies

63
Q

Disseminated Intravascular Coagulation (what (2), etiology (DIC is a _______ complication, extrinsic pathway, intrinsic pathway)

A

Imbalance between the natural procoagulant and anticoagulant systems (abnormal blood clotting throughout the body’s blood vessels. You may develop DIC if you have an infection or injury that affects the body’s normal blood clotting process.)

Unregulated thrombin activity, profuse fibrin production from fibrinogen, microvasculature thrombi, platelet consumption, and microangiopathic hemolytic anemia

etiology:
- DIC is a secondary complication (septic, certain cancers)
- Extrinsic pathway is activated by damage to the endothelial lining of blood vessels.
- Intrinsic pathway is activated when subendothelial tissue is exposed to the bloodstream and circulating factor XII comes in contact with the exposed tissue.

64
Q

Severe Sepsis and Septic Shock (what plays a big role in regulating the inflammatory response)

A

*Activated protein C plays a big role in regulating the inflammatory response

65
Q

Clinical Presentation DIC (3)

A

Systemic ischemia from the thrombi formation

Minor or major hemorrhage
- demarcation cyanosis: arterial blood clot in one extremity, acute, no signs until all platelets consumed

66
Q

Assessment DIC (7)

A

Complete history

Acute or chronic presentation

Low-grade bleeding

Unexpected thrombotic events

Signs and symptoms of inappropriate clotting

Demarcation cyanosis

Bleeding from the nose, gums, lungs, gastrointestinal tract, surgical sites, injection sites, and intravascular access sites; hematuria; petechial rashes.

67
Q

Care of the Patient DIC (6)

A

Onset is sudden and acute.

Constant reassessment

Dyspnea

Hypotension

Ischemic bowel (Gi bleed)

Signs and symptoms of the onset of shock (looks like shock)

68
Q

Laboratory Studies DIC (5)

A

Platelets (low)
Fibrinogen (low)
PT (high)
PTT (high)
d-dimer (high) -> measure of clot being broken down, will increase if it is

69
Q

Management DIC (9)

A

Eliminate the causative agent.

Antibiotic or antifungal therapy for sepsis

Antineoplastic therapy

Fluid replacement

Oxygen

Resolution of low-flow states

Activated protein C

Heparin therapy

FFP, cryoprecipitate, RBC

70
Q

remember that PCWP is a surrogate pressure for left atrial and left ventricular preload

A

wedge pressure

71
Q

cardiogenic shock (HR/SV/SVR/PCWP/MIXED VENOUS O2)

A

HR - high
SV - REALLY low
SVR - high
PCWP - high
O2 - low

72
Q

distributive shock (HR/SV/SVR/PCWP/MIXED VENOUS O2)

A

HR - high
SV - high
SVR - REALLY low
PCWP - low
O2 - high then low

73
Q

hypovolemic shock (HR/SV/SVR/PCWP/MIXED VENOUS O2)

A

HR - high
SV - REALLY low
SVR - high
PCWP - low or no change
O2 - high

74
Q

neurogenic shock (HR/SV/SVR/PCWP/MIXED VENOUS O2)

A

HR - low
SV - dont know
SVR - REALLY low

75
Q

treatment options: cardiogenic

A

insult: decreased CO

tx: inotropes
- afterload REDUCTION
- diuresis
- INcreased contractility

76
Q

treatment options: distributive (A,S,N)

A

insult: decreased SVR

tx:
- volume then vasopressors

77
Q

treatment options: hypovolemic

A

insult: decreased volume

tx:
- volume then vasopressors if unable to maintain MAP with volume